These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 12632604
1. [Reconsideration of glucocorticoid therapy for rheumatoid arthritis]. Ichikawa Y. Ryumachi; 2002 Dec; 42(6):859-62. PubMed ID: 12632604 [No Abstract] [Full Text] [Related]
7. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial. Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, Hakala M, Puolakka K, Julkunen H, Luosujärvi R, Möttönen T, FIN-RACo Trial Group. Arthritis Rheum; 2009 May 24; 60(5):1222-31. PubMed ID: 19404945 [Abstract] [Full Text] [Related]
8. Low dose prednisolone for treatment of RA. Kirwan J, Boers M. Ann Rheum Dis; 2004 Nov 24; 63(11):1533-4; author reply 1534. PubMed ID: 15479919 [No Abstract] [Full Text] [Related]
10. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone. Korthals-de Bos I, Van Tulder M, Boers M, Verhoeven AC, Adèr HJ, Bibo J, Boonen A, Van Der Linden S. J Rheumatol; 2004 Sep 02; 31(9):1709-16. PubMed ID: 15338488 [Abstract] [Full Text] [Related]
11. [Remission induction after pentoxifylline treatment in a patient with rheumatoid arthritis]. Ishii O, Yamada H, Ohya S, Moriuchi E, Kase C, Ichikawa Y, Yamasaki K. Ryumachi; 1997 Dec 02; 37(6):810-5. PubMed ID: 9492569 [Abstract] [Full Text] [Related]
12. Benefits of low-dose corticosteroids in rheumatoid arthritis. Cohen MD, Conn DL. Bull Rheum Dis; 1997 Jun 02; 46(4):4-7. PubMed ID: 9188203 [No Abstract] [Full Text] [Related]
13. Corticosteroids in rheumatoid arthritis. Haslock I. Br J Hosp Med; 1997 Jun 02; 56(1):50. PubMed ID: 8831016 [No Abstract] [Full Text] [Related]
14. [Topical use of Rheumon-Gel in the combined treatment of patients with rheumatoid arthritis]. Cherevatov BG, Shelest AN, Volnenko NB, Cherevatova SKh. Ter Arkh; 1987 Jun 02; 59(12):100-2. PubMed ID: 3447280 [Abstract] [Full Text] [Related]
15. The BeSt story: on strategy trials in rheumatoid arthritis. Klarenbeek NB, Allaart CF, Kerstens PJ, Huizinga TW, Dijkmans BA. Curr Opin Rheumatol; 2009 May 02; 21(3):291-8. PubMed ID: 19318946 [Abstract] [Full Text] [Related]
16. Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients? Pincus T, Sokka T. Rheumatology (Oxford); 2006 May 02; 45(5):497-9. PubMed ID: 16537578 [No Abstract] [Full Text] [Related]
17. [Update drug therapy of juvenile rheumatoid arthritis]. Watanabe N. Ryumachi; 1996 Aug 02; 36(4):670-5. PubMed ID: 8911086 [No Abstract] [Full Text] [Related]
19. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs. Malysheva OA, Wahle M, Wagner U, Pierer M, Arnold S, Häntzschel H, Baerwald CG. J Rheumatol; 2008 Jun 09; 35(6):979-85. PubMed ID: 18412314 [Abstract] [Full Text] [Related]
20. Safety of low- to medium-dose glucocorticoid treatment in rheumatoid arthritis: myths and reality over the years. Santiago T, da Silva JA. Ann N Y Acad Sci; 2014 May 09; 1318():41-9. PubMed ID: 24814757 [Abstract] [Full Text] [Related] Page: [Next] [New Search]